Clozapine toxicity in smoking cessation and with ciprofloxacin

Psychosomatics

Volumn 49, Issue 2, 2008, Pages 176-

  Brownlowe, Katherine ^a   Sola, Christopher ^b  

^a MAINE MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLOZAPINE; OLANZAPINE; ZIPRASIDONE;

ADULT; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MYOCARDITIS; REMISSION; RETREATMENT; SCHIZOAFFECTIVE PSYCHOSIS; SEPSIS; SMOKING CESSATION; URINARY TRACT INFECTION;

EID: 40549125602     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.psy.49.2.176     Document Type: Letter

References (5)

1. N.B. Sandson K.L. Cozza S.C. Armstrong Clozapine case series Psychosomatics 48 2007 170 175
2. D. Schrenk D. Brockmeier K. Morike A distribution study of CYP1A2 phenotypes among smokers and nonsmokers in a cohort study of healthy Caucasian volunteers Eur J Clin Pharmacol 53 1998 361 367
3. K.T. Batty T.M. Davis K.F. Ilett The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects B J Clin Pharmacol 39 1995 305 311
4. B. Eiermann G. Engel I. Johansson The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine Br J Clin Pharmacol 44 1997 439 446
5. P. Reid M. McArthur S. Pridmore Clozapine rechallenge after myocarditis Aust N Z J Psychiatry 35 2001 249